Skip to main content
Clinical Trials/JPRN-UMIN000012541
JPRN-UMIN000012541
Completed
未知

A prospective, randomized controlled trial assessing the efficacy and safety of cilostazol and aspirin therapy versus aspirin therapy for the prevention of vascular events in patietns undergoing coronary stent implantation - CATS-I Trial: Cilostazol and Aspirin versus Aspirin Therapy against Vascular Events after Coronary Stent Implantation Trial

Koseikai Takai Hospital0 sites700 target enrollmentDecember 10, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Koseikai Takai Hospital
Enrollment
700
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 10, 2013
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Koseikai Takai Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) hemostatic disorder or active pathologic bleeding, including hemophilia, capillary fragility, intracranial hemorrhage, gastrointestinal bleeding, urinary tract bleeding, hemoptysis and vitreous hemorrhage 2\) Known allergy to aspirin or cilostazol 3\) Malignancies or other comorbid conditions with a life expectancy of less than 2 years 4\) Planned major surgery necessitating discontinuation of antiplatelet therapy within the 2 years after enrollment 5\) Pregnancy 6\) Circumstances that would have made follow\-up impossible

Outcomes

Primary Outcomes

Not specified

Similar Trials